U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07111546) titled 'A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]' on Aug. 01.
Brief Summary: An open-label, multicenter, phase II clinical study to evaluate the efficacy and safety of LBL-024 in combination with other drugs for the treatment of patients with advanced solid tumour.
Study Start Date: Sept. 26
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumour
Intervention:
DRUG: LBL-024 for Injection
Intravenous infusion.
DRUG: Durvalumab Injection
Intravenous infusion.
DRUG: Cisplatin Injection
Intravenous infusion.
DRUG: Gemcitabine Hydrochloride for Injection
Intravenou...